Jamjoom Pharmaceuticals Factory Co. at 133.40, -1.33% today, -5.39% over five days, -7.36% year-to-date. Volume subdued at 0.3x average. The session recorded 2,146 trades at 0.3x normal volume. Price is trading 0.77% below intraday VWAP at 134.43.
Flow is neutral: balanced order flow, smart money neutral. Order flow is balanced with no clear directional bias from either order book or smart money indicators. Risk profile is moderate: defensive beta (0.86) with moderate volatility. Risk texture shows max drawdown at 10.9% with Sharpe ratio at -1.91.
Stochastic is oversold at 6.7 while RSI remains neutral-low at 38.4. Trend strength is weak; the downtrend bias lacks conviction. Price is testing support at 133.5; resistance at 137.9 (3.4% above). Support sits 0.1% above current price while resistance is 3.4% above. Within the 52-week range (134.0–183.8), price is 27.4% below the high.
The information environment is quiet with no tracked headlines. News mix is neutral: 0 positive vs 0 negative items over 7 days from 0 total tracked. Scale anchor: market cap is 9.9B SAR in the PHARMA,_BIOTECH_AND_LIFE_SCIENCE sector.
Positioning reflects rank 3 of 3 in PHARMA,_BIOTECH_AND_LIFE_SCIENCE, trailing TASI by 13.42% YTD. Against a sector average daily return of -1.05%, the stock's daily return measured -2.44%, an underperformance of 1.39 percentage points. Note: intraday change and daily return measures differ due to calculation basis. Watch whether support at 133.5 holds.
Flow:NEUTRAL
Levels:AT SUPPORT
Risk:MODERATE
Watch whether support at 133.5 holds.
Informational only. Not financial advice.
Price Chart
661 trading days
Since Jun 2023
Technical Analysis
DOWNTREND
RSI (14)
29.1
Oversold
Volatility (20D)
22.17%
Support
132.37
Resistance
135.47
Moving Averages
SMA 20
140.94
SMA 50
142.74
SMA 200
157.00
MA: Bearish
RSI: Oversold
About Jamjoom Pharmaceuticals Factory Co.
Jamjoom Pharmaceuticals Factory is a prominent player in the pharmaceutical industry based in Saudi Arabia. As a manufacturer, the company's primary function is to develop, produce, and distribute a broad range of pharmaceutical products. Jamjoom Pharmaceuticals serves multiple sectors, including healthcare, hospitals, and pharmacies, delivering essential medicines that cater to various medical needs.
The company's product portfolio includes both prescription medications and over-the-counter drugs, addressing therapeutic areas such as cardiovascular health, diabetes management, and ophthalmology. This diverse range of offerings underscores its commitment to enhancing healthcare and improving patient outcomes across the region.
Jamjoom Pharmaceuticals Factory's role in the financial market is significant, particularly within the Middle Eastern pharmaceutical sector. It contributes to the local economy by supporting healthcare infrastructure and advancing medical care standards. The company's involvement in research and development further solidifies its position as a key player, continuously striving to bring innovative solutions to the healthcare industry. By focusing on quality and accessibility, Jamjoom Pharmaceuticals is pivotal in meeting the growing medical demands of the population.